You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Treat above and below the knee with the HawkOne™ directional atherectomy system to restore blood flow by removing plaque in patients with peripheral arterial disease (PAD). The HawkOne device treats all plaque morphologies, including severe calcium. Enhanced crossing and simpler cleaning make your procedure more efficient. If your treatment goal is to make a small channel or to maximise luminal gain, choose the Medtronic directional atherectomy system to preserve a patient's native vessel and keep future treatment options open.
Product DetailsRemove plaque that impedes blood flow and circulation in the legs with the TurboHawk™ peripheral plaque excision system. Choose from a High Efficiency Cutter model that can tackle calcified plaque or a Smooth Cutter model that can treat mild-to-moderately calcified lesions. Proven clinically in the landmark DEFINITIVE LE trial, the study found that diabetic PAD patients fared as well as nondiabetics and that claudicants had high patency at 12 months when treated with plaque excision technology. 1
Product DetailsPreserve the native vessel and keep future treatment options open for PAD patients when you treat with the SilverHawk™ peripheral plaque excision system. Use the device's directional cutter to shave soft-to-mild plaque, while the nosecone captures the material for removal from the artery. The SilverHawk technology is backed by the landmark DEFINITIVE LE clinical study, which found that PAD patients with critical limb ischemia who were treated with plaque excision experienced a high rate (95%) of limb salvage at 12 months.1
Product DetailsProduct names on this page are trademarks or registered trademarks of Medtronic.
This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorisation for use.
McKinsey et al. JACC: Aug 2014;7;8;923-33